Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-27

Clinical Trial Update: Sulindac and Plant Compounds in Preventing Colon Cancer [NA]

View source ↗

Summary

A terminated clinical trial evaluating sulindac and plant compounds for the prevention of colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clinoril (sulindac) (sulindac)
  • plant compounds

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Colorectal Cancer | NA | Status: TERMINATED